Current filters:


1 to 9 of 97526 results

Novartis sees negative currency impact in 4th-qtr 2014; gives positive 2015 guidance

Novartis sees negative currency impact in 4th-qtr 2014; gives positive 2015 guidance


Swiss pharma major Novartis, now the world’s largest drugmaker by sales, this morning posted financial…


Actavis to acquire UK generics firm Auden Mckenzie


Ireland-headquartered generic major Actavis said today that it has reached agreement to acquire UK-based…

ActavisAuden MckenzieGenericsMergers & AcquisitionsUK

Aspen buys rights to an anti-coagulant product from Novartis


Aspen Global Inc, a wholly-owned subsidiary of South Africa’s Aspen Holdings, has entered into an agreement…

Aspen Global IncAspen HoldingsHematologyMergers & AcquisitionsMono-EmbolexNovartisPharmaceutical

Rockwell's Triferic cleared for marketing by US FDA


The US Food and Drug Administration has approved US biopharma company Rockwell Medical’s Triferic (ferric…

Nephrology and HepatologyPharmaceuticalRegulationRockwell MedicalTrifericUSA

Innovation and confidence at JP Morgan conference, says Edison analyst


The atmosphere at this year's annual JPMorgan Conference in San Francisco was understandably buoyant,…

BiotechnologyFinancialMergers & AcquisitionsResearch

CIPA and KEFEA discuss initiatives to improve Cyprus’ pharma investment climate


The potential to attract investments in the pharmaceutical industry and develop joint initiatives to…

FinancialHealthcarePharmaceuticalRest of the World

Kite Pharma expands CAR-T deal with Sourasky Medical Center


US clinical-stage biopharma company Kite Pharma, focused on developing engineered autologous T cell therapy…

BiotechnologyKite PharmaOncologyResearch

1 to 9 of 97526 results

Back to top